Industry update tracker: August 2026
A monthly index of company press releases and announcements shaping the real-world data (RWD), real-world evidence (RWE) and health technology assessment (HTA) landscape.
Carelon Research and Manifold Partner to Expand Real-World Evidence Access For Life Sciences Researchers
Carelon Research, a subsidiary of Elevance Health, and Manifold, an enterprise agent platform for life sciences, announced a strategic partnership that gives life sciences researchers and data analysts secure, scalable access to high-quality, analysis-ready, RWD in a protected environment, enabling faster, evidence-based decision-making. Through this collaboration, users can analyze Carelon RWD alongside third-party datasets without moving data outside their respective organizations, reducing risk and strengthening data protection. The partnership also enables users to link Carelon RWD with additional datasets to address evidence gaps for specialized analyses.
Century Health and GI Partners of Illinois Partner to Advance Real-World Evidence in IBD and MASH
Century Health, a national leader in AI-powered real-world clinical data and evidence generation, announced a strategic partnership with GI Partners of Illinois (GIP), the largest independent physician-led gastroenterology practice in Illinois, to build a comprehensive real-world data ecosystem across tens of thousands of patients to advance research in IBD and MASH. This collaboration will leverage Century Health's AI abstraction model, CHARM, which will unlock valuable clinical insights from both structured and unstructured data, including physician notes, pathology reports, laboratory data, imaging, and endoscopy reports that have historically required extensive manual abstraction.
Flatiron Health Expands NSCLC Panoramic Dataset with Comprehensive Biomarker Data Model, Enabling Precision Medicine Research at Unprecedented Scale
Flatiron Health, a leading healthtech company dedicated to improving cancer care and advancing research using RWD, announced the expansion of its non-small cell lung cancer (NSCLC) Panoramic dataset with a comprehensive biomarker data model, delivering specimen-level molecular detail at a scale of 345,000+ patients across early and advanced settings. This expansion enables researchers to more deeply explore biomarker-driven treatment patterns, patient outcomes and evolving testing practices across the NSCLC care journey.
Health Universe Partners with Atropos Health to Bring Trusted Real-World Evidence Directly into Clinical Workflows
Health Universe, the secure operating environment for agentic healthcare, announced a partnership with Atropos Health, the world’s largest creator of RWE for clinical decision-making. Through the partnership, healthcare organizations using Health Universe will gain seamless access to Atropos Health's clinical decision support capabilities directly within the platform, enabling clinicians to incorporate high-quality, patient-specific evidence into everyday care decisions.
Inovalon and OMNY Health Partner to Launch Linked Real-World Dataset to Accelerate Research And Improve Patient Outcomes
Inovalon, a leading provider of data and solutions empowering data-driven healthcare, and OMNY Health, a leading healthcare ecosystem for compliant RWD insights at scale, announced a strategic RWD partnership that combines Inovalon’s primary source closed claims data with OMNY Health’s EHR data and clinical notes. The dataset gives researchers and life sciences organizations a comprehensive view of disease progression, treatment patterns, and outcomes to support RWE studies and help accelerate access to new precision therapies for patients.
Maprium and Vitaccess: New Collaboration Helps Pharmaceutical Companies Generate Greater Value from Global Managed Access Programs
Maprium, the company behind the Managed Access Operating System, announced a strategic collaboration with Vitaccess, a patient-centered real-world research consultancy, to help pharmaceutical companies manage global Managed Access Programs (MAPs) while generating high-quality RWE through a single, connected approach.
Navidence Partners with Komodo Health to Advance Trusted, AI-Powered Healthcare Intelligence
Navidence, a technology company focused on supporting researchers in defining health data through the deployment of Computable Operational Definitions (CODefs), announced a strategic partnership with Komodo Health®, the leader in AI-powered healthcare intelligence, to integrate its Navigate:Code Lists into Komodo’s healthcare-native analytics AI platform, Marmot™. By integrating Navidence’s clinically and programmatically validated code lists and value sets into Marmot, healthcare and life sciences organizations will have access to standardized definitions for identifying and analyzing patient populations, enabling users to translate complex clinical concepts into computable definitions and conduct faster, more reproducible analyses.
OmicsBank Raises $2.25M to Expand Clinical Data Infrastructure Globally for Healthcare, Life Sciences, and Frontier AI Labs
OmicsBank, a clinical data infrastructure company connecting fragmented hospital data for drug development and healthcare AI, announced $2.25 million in seed funding from global venture capital and technology firm Redesign Health. The investment will support US expansion across health systems, pharmaceutical and biotechnology companies, CROs, and AI developers, while growing its clinical data network across Asia and the Middle East.
Truveta Outlines A Path Toward a Continuously Learning Healthcare System in New Peer-Reviewed Publication
Truveta announced the publication of a new peer-reviewed paper in JAMIA Open describing how health systems, artificial intelligence, and continuously updated clinical data can help realize a long-standing vision in medicine: a healthcare system that learns from every patient, every day. The paper, "From fragmented records to living evidence: health system-governed, artificial intelligence-driven, continuously updated real-world clinical data from Truveta," provides a comprehensive overview of the Truveta platform, including its health system governance model, AI-powered data harmonization, regulatory-grade quality framework, and continuously updated RWD representing more than 140 million patients.
| Register for free today to become a member of The Evidence Base and receive the latest news straight to your inbox. |